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LETTER TO THE EDITOR
Biologic therapy of cancer
Sir - A heavy volume, with the above title, has recently been
published (VT DeVita, S Hellman and SA Rosenberg (eds).
JB Lippincott Co: Philadelphia, 919 pp, 2nd edn, 1995). With
over 9000 references, it adds to the already immense literature
on tumour immunology. But is it a reliable guide? In the
article by WJ Storkus and MT Lotze on tumour antigens
recognised by immune cells there is a serious error. On page
65, they state 'Early evaluation of spontaneous tumour
models, for which no mutagen or viral etiology could be
established, suggested that such tumour cells were nonimmu-
nogenic.' In support of this statement they quote four
references, which include Hewitt, Blake and Walden
[Walder] (1976), and Middle and Embleton (1981). They
continue 'using modem techniques and more sensitive
detection procedures, this conclusion has been demonstrated
to be largely incorrect.'
Now Hewitt et al. (1976) and Middle and Embleton (1981)
used spontaneous tumours of recent origin arising in their
own colonies of inbred mice or rats. We might expect,
therefore, that the 'modern techniques and more sensitive
detection procedures' have been applied to the same class of
tumours. But this is not so. Among the 17 papers that the
authors reference, we find that the following tumours have
been used, all of which were chemically induced: CT26,
CMS-5, HSN, glioma 203, MCA 205, EL4 and WP4. Some
spontaneous tumours had been examined, such as Lewis
lung, B16 and RENCA, but not one of these could be
described as of recent origin, or growing in the precise strain
of origin. The B16 melanoma is an interesting example of a
tumour that has such a long history that it is almost lost in
the mists of time. In fact, it arose in 1954 in a C57/6J mouse
at the Jackson Laboratory, but its origin is described in a
journal not available in the UK [The Handbook on
Genetically Standardized Jax Mice, L Green, (ed.) 1st edn
1962, 2nd edn 1968]. I am indebted to the Librarian at the
Jackson Laboratory, Bar Harbour, Maine, for this informa-
tion.
Storkus and Lotze might have quoted a highly relevant
paper in connection with Hewitt's work. Van Pel et al. (1983)
actually tested two of Hewitt's tumours in his strain of mice
and detected immunogenicity. But it has been pointed out
(Scott, 1991) that these tumours had gone through many
transplant generations at the time of testing. There is a
further complication in that Hewitt's mice were not, strictly
speaking, inbred. They very honestly explained that their
colony consisted of multiple sublines. On p. 244 of their 1976
paper they wrote 'An implication of this routine is that the
mice contributing to any single experiment are representatives
of multiple sublines separated over an indefinite number of
generations'.
Forty years ago it was not unusual to state whether or not
the single line principle was being applied in the inbreeding of
animals [for instance, Revesz, (1958) told us that his
experimental animals were never permitted to deviate from
the inbred nucleus by more than two brother x sister
generations]. Today the point is not often mentioned.
Middle and Embleton (1981), in a classic study of
spontaneous tumours, made a very curious observation.
Whereas previously about a third of their tumours were
found to be immunogenic, when they continued to test their
tumours after an interval of time 28 of them in succession
were found to be non-immunogenic. Scott (1991) put forward
the suggestion that this change in behaviour might have been
owing to a lack of perfect inbreeding in the original colony,
which was corrected by the passage of time. This suggestion
was strongly supported by Embleton (1991), who pointed out
that the interval between his two series of experiments
amounted to a further 11 generations of inbreeding.
Bailey (1982) has drawn attention to the need for greater
care in the inbreeding of animals, and suggests that 30-40
generations are required, not the generally accepted figure of
20. Scott (1992) has summarised the requirements for a
strictly inbred strain.
Unless some workers are prepared to take on the labour of
repeating the work of Middle and Embleton in very strictly
inbred animals it is difficult to see how they can be refuted.
Claims have been made that spontaneous tumours of
recent origin can be immunogenic in strictly inbred animals
(for instance Key et al., 1984). But perhaps the work of
Middle and Embleton carries more weight in that they
observed a change in the behaviour of their tumours with the
passage of time. The results of their first series ofexperiments
could be regarded as a confirmation of Key et al.
OCA Scott,
31 Kensington Square,
London, W8 5HH, UK
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